- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Colon Cancer in Hong Kong
Total 1010 results
-
Tempus AIGlaxoSmithKlineActive, not recruitingMelanoma | Head and Neck Cancer | Pancreatic Cancer | Esophageal Cancer | Solid Tumor | Metastatic Cancer | Endometrial Cancer | Urologic Cancer | Breast Tumor | Locally Advanced Solid Tumor | Lung Tumor | Colon Tumor, MalignantUnited States
-
Jennerex BiotherapeuticsCompletedHCC | Hepatocellular Carcinoma | Liver CancerKorea, Republic of, United States, Hong Kong, Canada, Germany, France, Taiwan
-
Translational Oncology Research InternationalGenentech, Inc.Completed
-
BioAtla, Inc.RecruitingMelanoma | Head and Neck Cancer | Non Small Cell Lung Cancer | Triple Negative Breast CancerUnited States, Hong Kong, Taiwan, Spain, Greece, Germany, Italy, Poland
-
Xcovery Holdings, Inc.Active, not recruitingNon-small Cell Lung CancerSpain, United States, China, Korea, Republic of, Hong Kong, United Kingdom, Poland, Israel, Germany, France, Argentina, Australia, Brazil, Canada, Czechia, Italy, Netherlands, Russian Federation, Turkey, Belgium
-
Taiho Pharmaceutical Co., Ltd.CompletedCervical CancerJapan, Korea, Republic of, Taiwan
-
Eisai Inc.CompletedNon-small Cell Lung CancerUnited States, Hong Kong, Taiwan, Korea, Republic of, Singapore, Thailand, Malaysia
-
Translational Oncology Research InternationalGenentech, Inc.Completed
-
NSABP Foundation IncPfizer; Genomic Health®, Inc.CompletedBreast CancerUnited States, Canada
-
MuReva Phototherapy Inc.Active, not recruitingHead and Neck Cancer | Oral Mucositis (Ulcerative) | Oral Mucositis (Ulcerative) Due to Radiation | Oral Mucositis (Ulcerative) Due to Antineoplastic TherapyUnited States
-
Bristol-Myers SquibbCompletedVarious Advanced CancerUnited States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, United Kingdom
-
Daiichi SankyoRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Japan, Netherlands, Taiwan
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
Hoffmann-La RocheCompletedBreast CancerChina, Hong Kong, France, Spain, Italy, Turkey, Brazil, Egypt, Poland, India, Saudi Arabia
-
Cancer Institute and Hospital, Chinese Academy...Completed
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerCanada, Italy, United Kingdom, Spain, Netherlands, Singapore, Germany, Hong Kong, Japan, France, Korea, Republic of, United States
-
CelgeneCompleted
-
Bristol-Myers SquibbCompleted
-
Novartis PharmaceuticalsCompletedALK-positive Non-small Cell Lung CancerUnited States, France, Italy, United Kingdom, Taiwan, Turkey, Belgium, Germany, Canada, Singapore, Spain, Korea, Republic of, Netherlands, Russian Federation, Brazil, Hong Kong, Australia
-
Proacta, IncorporatedTerminatedLung CancerUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Gastric CancerChina, United States, Belgium, France, Taiwan, United Kingdom, Canada, Spain, Italy, Australia, Russian Federation, Thailand, Korea, Republic of, Israel, Germany, Peru, Argentina, Japan, Hong Kong, New Zealand, Mexico, Netherlands
-
Accuray IncorporatedCompletedProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
Hoffmann-La RocheCompletedAnemiaBelgium, Italy, Poland, Spain, Hong Kong, Canada, France, Greece, Czech Republic, Austria, Estonia, Hungary, Australia, Germany, Finland
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Colorectal CancerCanada, Taiwan, Belgium, Germany, Spain, Italy, Czechia, Switzerland, Australia, United States, Japan, Singapore, United Kingdom, France, Israel, Hong Kong, Korea, Republic of
-
NantCell, Inc.CompletedMetastatic Colorectal CancerUnited States, Italy, France, Russian Federation, Spain, Hungary, Poland, Singapore, Hong Kong, India
-
xCuresCancer CommonsAvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesMelanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditionsUnited States
-
National Cancer Centre, SingaporeUniversity of Sydney; Australasian Gastro-Intestinal Trials Group; INDOX Cancer...Active, not recruitingColorectal CancerAustralia, Saudi Arabia, India, China, Malaysia, Korea, Republic of, Singapore, Indonesia, New Zealand, Sri Lanka
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerUnited Kingdom, Taiwan, Belgium, Spain, Canada, Italy, Singapore, Japan, Russian Federation, Hong Kong, Thailand, Korea, Republic of, Norway, Australia, France, Sweden, United States, New Zealand
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, France, Taiwan, Hungary, Germany, Singapore, Austria, Netherlands, Australia, Russian Federation, Spain, Canada, Israel, Japan, Korea, Republic of, Italy, United States, United Kingdom, Brazil, Hong Kong, Czech Republic, South...
-
Jonsson Comprehensive Cancer CenterPharmacia and UpjohnCompletedGastric Cancer | Esophageal CancerUnited States
-
Vietnam Military Medical UniversityCompleted
-
MedImmune LLCCompletedStage III Non-small Cell Lung Cancer | UnresectableUnited States, Canada, Italy, Spain, France, Hong Kong, Portugal, Taiwan, Poland
-
VA Office of Research and DevelopmentRecruitingRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Oligometastasis | Oligorecurrence | De Novo Prostate CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Completed
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
ZionexaGE Healthcare; Medpace, Inc.; Simbec-Orion GroupRecruitingMetastatic Breast CancerUnited States
-
US Department of Veterans AffairsCompleted
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted
-
AstraZenecaCompletedNon-Small Cell Lung CancerPhilippines, China, Malaysia, Japan, Hong Kong, Taiwan, Thailand, Indonesia, Singapore
-
Hoffmann-La RocheCompletedColorectal CancerCanada, United States, Italy, Korea, Republic of, United Kingdom, Belgium, Russian Federation, Hong Kong, Spain, Australia, Poland
-
US Department of Veterans AffairsCompletedColorectal CancerUnited States
-
Pharmacyclics LLC.TerminatedNon-Small Cell Lung CarcinomaUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Radiation Toxicity | Oral Complications of Radiation TherapyUnited States
-
NovoCure GmbHMerck Sharp & Dohme LLCRecruiting
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Radiation ToxicityUnited States, Canada
-
Hoffmann-La RocheCompletedPancreatic CancerAustralia, Hong Kong, Romania, Germany, Russian Federation, United Kingdom, Bulgaria, Malaysia, Latvia, Slovenia, Croatia, Brazil, Italy, Lithuania, India, Mexico, Singapore, Peru, Ukraine
-
Eli Lilly and CompanyCompleted
-
Bristol-Myers SquibbActive, not recruitingHepatocellular Carcinoma | Hepatoma | Liver Cell Carcinoma | Liver Cancer, Adult | Liver Cell Carcinoma, AdultChile, Brazil, Argentina, China, Czechia, France, Hong Kong, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Singapore, Spain, Taiwan, Turkey
-
NovartisCompletedBreast CancerUnited States
-
Profound Medical Inc.RecruitingProstate Cancer | Prostate AdenocarcinomaUnited States, Canada, Finland